Drug Delivery in Cancer Therapy, Quo Vadis?-Reference-Cited by-同舟云学术

Drug Delivery in Cancer Therapy, Quo Vadis?

Published:2018-03-19 Issue:9 Volume:15 Page:3603-3616
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Lu Zheng-Rong¹^ORCID,Qiao Peter¹

Affiliation:

1. Case Center for Biomolecular Engineering, Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio 44106, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.8b00037

Reference158 articles.

1. DRUG-CARRIER POTENTIAL OF LIPOSOMES IN CANCER CHEMOTHERAPY

2. Cancer Drug Delivery: Considerations in the Rational Design of Nanosized Bioconjugates

3. Engineering and physical sciences in oncology: challenges and opportunities

4. Biological rationale for the design of polymeric anti-cancer nanomedicines

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methotrexate-loaded manganese nitrogen dual-doped carbon quantum dots as targeted nano drug-delivery system for potential use in cancer theranostics;Journal of Photochemistry and Photobiology A: Chemistry;2024-10

2. A facile one-step self-assembly strategy for constructing biocompatible and pH-sensitive polyphenol-based nanoparticles for high-efficiency tumor therapy;Journal of Industrial and Engineering Chemistry;2024-08

3. Biopolymer-Based Nanomedicine for Cancer Therapy: Opportunities and Challenges;International Journal of Nanomedicine;2024-07

4. Active targeted drug delivery system constructed from functionalized pillararenes for chemo/photodynamic synergistic therapy;Frontiers of Chemical Science and Engineering;2024-06-24

5. Long-Acting Strategies for Antibody Drugs: Structural Modification, Controlling Release, and Changing the Administration Route;European Journal of Drug Metabolism and Pharmacokinetics;2024-04-18